Monoclonal Mouse anti‑Human HIRIP3 Antibody (clone 3B3, IHC, WB) LS‑C133549
Monoclonal Mouse anti‑Human HIRIP3 Antibody (clone 3B3, IHC, WB) LS‑C133549
Antibody:
HIRIP3 Mouse anti-Human Monoclonal (3B3) Antibody
Application:
IHC, IHC-P, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
HIRIP3 Mouse anti-Human Monoclonal (3B3) Antibody
Application:
IHC, IHC-P, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
HIRIP3 antibody LS-C133549 is an unconjugated mouse monoclonal antibody to human HIRIP3. Validated for ELISA, IHC and WB.
Target
Human HIRIP3
Synonyms
HIRIP3 | HIRA-interacting protein 3 | HIRA interacting protein 3
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1,k
Monoclonal
Conjugations
Unconjugated
Purification
Purified from ascites by Protein A
Immunogen
HIRIP3 (NP_003600, 447 aa ~ 555 aa) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Applications
- IHC
- IHC - Paraffin (0.7 µg/ml)
- Western blot
- ELISA
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Usage
Immunohistochemistry: Formalin-fixed paraffin-embedded sections. Western Blot: Recombinant protein.
Storage
Store at -20°C or lower. Aliquot to avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
Western blot
Reactivity:
Human
Range:
0.312-20 ng/ml
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Mouse
Applications:
Flow Cytometry
Species:
Human, Mouse, Rat
Applications:
IHC, ELISA
Reactivity:
Mouse
Range:
15.6-1000 pg/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/28/2024